MediXall (MDXL) Free Cash Flow (2019 - 2024)
MediXall's Free Cash Flow history spans 8 years, with the latest figure at -$397742.0 for Q3 2024.
- For Q3 2024, Free Cash Flow fell 50.71% year-over-year to -$397742.0; the TTM value through Sep 2024 reached -$1.2 million, up 26.08%, while the annual FY2023 figure was -$1.2 million, 65.49% up from the prior year.
- Free Cash Flow reached -$397742.0 in Q3 2024 per MDXL's latest filing, down from -$294238.0 in the prior quarter.
- In the past five years, Free Cash Flow ranged from a high of -$201446.0 in Q4 2023 to a low of -$1.5 million in Q2 2021.
- Average Free Cash Flow over 5 years is -$772331.4, with a median of -$830688.0 recorded in 2020.
- Peak YoY movement for Free Cash Flow: plummeted 81.27% in 2021, then skyrocketed 70.61% in 2023.
- A 5-year view of Free Cash Flow shows it stood at -$1.3 million in 2020, then increased by 26.66% to -$982120.0 in 2021, then skyrocketed by 39.08% to -$598281.0 in 2022, then surged by 66.33% to -$201446.0 in 2023, then crashed by 97.44% to -$397742.0 in 2024.
- Per Business Quant, the three most recent readings for MDXL's Free Cash Flow are -$397742.0 (Q3 2024), -$294238.0 (Q2 2024), and -$308848.0 (Q1 2024).